Literature DB >> 95338

A rat model (using a semipurified diet) of the fetal alcohol syndrome.

B T Sherwin, S Jacobson, S L Troxell, A E Rogers, R W Pelham.   

Abstract

A semipurified liquid diet was used to develop a chronic rat model of the fetal alcohol syndrome. Control female rats gained weight normally, reproduced normally, and gave birth to normal litters on this diet. Increased neonatal mortality, decreased neonatal weights, and altered sex ratios were observed in offspring of experimental alcoholic animals. Preliminary histological results include a mild delay in cell lamination patterns in the cerebral cortex at 4 days postnatal in alcoholic offspring as well as decreased formation of dendritic spines at 7 days postnatal.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 95338

Source DB:  PubMed          Journal:  Curr Alcohol        ISSN: 0161-8504


  4 in total

Review 1.  Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder.

Authors:  Shonagh K O'Leary-Moore; Scott E Parnell; Robert J Lipinski; Kathleen K Sulik
Journal:  Neuropsychol Rev       Date:  2011-03-29       Impact factor: 7.444

2.  Dihydromyricetin prevents fetal alcohol exposure-induced behavioral and physiological deficits: the roles of GABAA receptors in adolescence.

Authors:  Jing Liang; Yi Shen; Xuesi M Shao; Michael B Scott; Eddie Ly; Stephanie Wong; Albert Nguyen; Kevin Tan; Bill Kwon; Richard W Olsen; Igor Spigelman
Journal:  Neurochem Res       Date:  2014-03-28       Impact factor: 3.996

3.  Teratogenic and behavioral anomalies induced by acute exposure of mice to ethanol and their possible relation to fetal brain DNA synthesis.

Authors:  A A Ciociola; R F Gautieri
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

Review 4.  A comparison of the different animal models of fetal alcohol spectrum disorders and their use in studying complex behaviors.

Authors:  Anna R Patten; Christine J Fontaine; Brian R Christie
Journal:  Front Pediatr       Date:  2014-09-03       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.